3 days popular7 days popular1 month popular3 months popular

No improvement in MS progression offered by cannabis constituent

The first large non-commercial clinical study to investigate whether the main active constituent of cannabis (tetrahydrocannabinol or THC) is effective in slowing the course of progressive multiple sclerosis (MS), shows that there is no evidence to suggest this; although benefits were noted for those at the lower end of the disability scale. The study is [...]

The Progression Of Multiple Sclerosis Unaffected By Active Ingredient Of Cannabis

The first large non-commercial study to investigate whether the main active constituent of cannabis (tetrahydrocannabinol or THC) is effective in slowing the course of progressive multiple sclerosis (MS) shows that there is no evidence to suggest this; although benefits were noted for those at the lower end of the disability scale. The CUPID (Cannabinoid Use [...]